Stratasys
SSYS
8.06
-0.18
-2.18%
Stratasys
US · SSYS
#3488 by market cap
8.06
-0.18
-2.18%
Live - 5344 symbols - heartbeat 34s ago
· 2026-10-08 11:37
Pre-market
8.16
-0.97%
After-hours
8.25
+0.12%
Overnight
8.21
-0.36%
- Market cap
- 705.95M
- P/E (TTM)i
- -5.88
- P/Bi
- 0.86
- EPSi
- -1.28
- Div yieldi
- 0.00%
- 52W posi
- 13%
Reader sentiment
Are you bullish or bearish on SSYS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.57, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.73% YoY
Margins
- Gross margin
- 41.24%
- Operating margin
- -13.15%
- Net margin
- -18.92%
Key ratios & quality
- Altman Z-Scorei
- -0.57
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 663.24M | 636.08M | 520.82M | 607.22M | 651.48M | 627.60M | 572.46M | 551.10M |
| Gross profit | 325.22M | 313.69M | 219.39M | 260.08M | 276.47M | 267.02M | 256.82M | 227.29M |
| Selling & admin expenses | 235.11M | 231.14M | 205.22M | 250.94M | 240.75M | 260.18M | 243.34M | 222.47M |
| Research & development | 98.96M | 94.25M | 84.01M | 88.30M | 92.88M | 94.43M | 99.14M | 77.30M |
| Operating profit | -8.85M | -11.70M | -69.84M | -79.16M | -57.16M | -87.58M | -85.66M | -72.49M |
| Pretax profit | -8.21M | -7.14M | -456.57M | -66.84M | -17.79M | -84.59M | -83.99M | -62.10M |
| Tax | 4.74M | 3.52M | -16.39M | -3.91M | 5.45M | 5.78M | 2.97M | 3.08M |
| Net profit | -11.23M | -11.08M | -444.12M | -61.98M | -28.97M | -123.07M | -120.28M | -104.29M |
| Basic EPS | 0 | 0 | -8 | -1 | 0 | -2 | -2 | -1 |
| Diluted EPS | -0.22 | -0.20 | -8.08 | -0.98 | -0.44 | -1.79 | -1.70 | -1.28 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 136.05M | 138.09M | 136.97M | 140.00M | 132.70M | 137.61M |
| Gross profit | 60.24M | 59.49M | 56.09M | 51.46M | 55.36M | 58.24M |
| Selling & admin expenses | 53.85M | 56.19M | 58.24M | 54.19M | 62.74M | 52.24M |
| Research & development | 18.79M | 19.92M | 20.56M | 18.03M | 19.15M | 19.46M |
| Operating profit | -12.40M | -16.62M | -22.70M | -20.76M | -26.53M | -13.47M |
| Pretax profit | -10.93M | -13.33M | -20.05M | -17.79M | -23.80M | -10.18M |
| Tax | 455.00K | 1.04M | 524.00K | 1.06M | 25.00K | 6.68M |
| Net profit | -13.05M | -16.75M | -55.63M | -18.85M | -23.83M | -16.87M |
| Basic EPS | 0 | 0 | -1 | 0 | 0 | 0 |
| Diluted EPS | -0.18 | -0.20 | -0.65 | -0.22 | -0.28 | -0.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 684.17M | 659.07M | 560.49M | 800.70M | 700.22M | 560.10M | 512.96M | 581.98M |
| Cash & ST investments | 393.17M | 321.78M | 299.09M | 502.18M | 327.84M | 162.59M | 150.70M | 244.53M |
| Inventory | 123.52M | 168.50M | 131.67M | 129.15M | 194.05M | 192.98M | 179.81M | 145.24M |
| Total assets | 1.39B | 1.38B | 990.00M | 1.28B | 1.26B | 1.13B | 1.03B | 1.07B |
| Total current liabilities | 175.78M | 159.92M | 132.15M | 210.47M | 210.65M | 176.43M | 167.21M | 163.04M |
| Short-term debt | 5.14M | 9.29M | 9.28M | 7.28M | 7.17M | 6.50M | 6.94M | 6.60M |
| Long-term debt | 22.00M | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 246,139,000.00 | 224,368,000.00 | 230,407,000.00 | 321,208,000.00 | 300,358,000.00 | 249,066,000.00 | 236,755,000.00 | 230,864,000.00 |
| Total equity | 1.14B | 1.16B | 759.60M | 956.01M | 959.43M | 884.84M | 792.99M | 842.90M |
| Retained earnings | -1.53B | -1.54B | -1.99B | -2.05B | -2.08B | -2.20B | -2.32B | -2.42B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 507.63M | 614.85M | 603.68M | 581.98M | 573.63M | 555.48M |
| Cash & ST investments | 150.06M | 254.57M | 254.97M | 244.53M | 237.79M | 212.53M |
| Inventory | 169.88M | 164.59M | 159.34M | 145.24M | 143.57M | 143.93M |
| Total assets | 1.02B | 1.14B | 1.09B | 1.07B | 1.07B | 1.05B |
| Total current liabilities | 168.07M | 166.05M | 165.25M | 163.04M | 180.70M | 159.45M |
| Short-term debt | 6.92M | 7.04M | 7.28M | 6.60M | 7.14M | 6.55M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 238,303,000.00 | 236,606,000.00 | 234,683,000.00 | 230,864,000.00 | 247,260,000.00 | 230,714,000.00 |
| Total equity | 784.84M | 902.38M | 852.53M | 842.90M | 825.61M | 818.59M |
| Retained earnings | -2.33B | -2.35B | -2.41B | -2.42B | -2.45B | -2.47B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 63.71M | -11.19M | 27.80M | 35.82M | -75.41M | -61.65M | 7.83M | 15.14M |
| Depreciation & amortization | 61.25M | 50.94M | 49.56M | 56.10M | 59.77M | 48.97M | 45.34M | 43.17M |
| Free cash flow | 38.90M | -36.37M | -1.21M | 9.07M | -95.16M | -76.67M | -4.89M | -11.91M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | 218.85M | 0 | 0 | -2.00M | 119.29M |
| Ending cash balance | 393.73M | 293.60M | 272.22M | 243.29M | 150.69M | 82.86M | 71.08M | 95.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 4.54M | -1.11M | 6.91M | 4.81M | 2.39M | -18.68M |
| Depreciation & amortization | 10.77M | 10.57M | 10.69M | 11.15M | 11.42M | 11.08M |
| Free cash flow | 304.00K | -11.94M | 2.10M | -2.37M | -2.30M | -22.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 70.89M | 71.92M | 72.32M | 95.36M | 72.50M | 93.24M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1.05 | -0.94 | -46.30 | -7.23 | -3.03 | -13.35 | -14.34 | -12.75 |
| ROA %i | -0.86 | -0.78 | -37.42 | -5.47 | -2.28 | -10.28 | -11.12 | -9.92 |
| ROIC %i | -1.06 | -1.21 | -45.28 | -7.07 | -2.97 | -13.09 | -13.92 | -12.31 |
| 5-year avg ROE %i | -17.98 | -17.22 | -11.69 | -11.81 | -11.71 | -14.17 | -16.85 | -10.14 |
| EBIT margin %i | -1.33 | -1.84 | -13.41 | -13.04 | -8.77 | -13.95 | -14.96 | -13.15 |
| FCF / sales %i | 5.87 | -- | -- | 1.49 | -- | -- | -- | -- |
| Current ratioi | 3.89 | 4.12 | 4.24 | 3.80 | 3.32 | 3.17 | 3.07 | 3.57 |
| Quick ratioi | 3.02 | 2.84 | 3.07 | 3.00 | 2.24 | 1.90 | 1.82 | 2.48 |
| Debt / assetsi | 1.96 | 1.57 | 2.21 | 1.17 | 1.42 | 1.65 | 3.12 | 2.47 |
| LT debt / equityi | 1.93 | 1.08 | 1.65 | 0.80 | 1.11 | 1.37 | 3.17 | 2.36 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -1.59 | -1.84 | -7.98 | -2.90 | 0.80 | 6.41 | -1.95 | -5.43 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -38.45 | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -13.00 | -11.22 | -15.13 | -12.75 | -14.29 | -13.39 |
| ROA %i | -10.11 | -8.86 | -11.74 | -9.92 | -10.98 | -10.53 |
| ROIC %i | -12.63 | -10.92 | -14.58 | -12.31 | -13.79 | -12.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -13.04 | -11.37 | -10.94 | -13.15 | -15.81 | -15.25 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.02 | 3.70 | 3.65 | 3.57 | 3.17 | 3.48 |
| Quick ratioi | 1.82 | 2.48 | 2.46 | 2.48 | 2.19 | 2.34 |
| Debt / assetsi | 3.06 | 2.73 | 2.86 | 2.47 | 2.49 | 2.42 |
| LT debt / equityi | 3.10 | 2.66 | 2.79 | 2.36 | 2.37 | 2.30 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Products is the largest reported line at 67.39% of revenue, across 2 reported segments.
- Services follows at 32.61%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Products67.39%
Services32.61%
Quote time 2026-10-08 11:37:54 · For reference only, not investment advice and not tailored to your situation.